Oxford Biomedica Share News (OXB)

Anglo Pacific Group: Finncap cuts target price from 320p to 279p staying with its buy recommendation.Ashtead Group: Citi takes target price from 660p to 750p and maintains a buy recommendation.Centrica: Berenberg ups target price from 370p to 380p keeping a hold recommendation.Coal of Afica: Investec shifts target price from 16p to 15p keeping a hold recommendation.C&W Communications: Jefferies shifts target price from 42p to 47p and reiterates a hold recommendation.Darty: Cantor Fitzgerald downgrades to sell with a target price of 60p.Dixons Retails: Cantor Fitzgerald ups target price from 42p to 50p and retains a buy recommendation.Great Portland Group: Morgan Stanley raises target price from 570p to 610p reiterating an overweight rating.ITE Group: N+1 Singer moves target price from 280p to 297p, while downgrading to hold.Legal & General Group: Citi increases target price from 165p to 181p. while leaving its neutral rating unchanged.Mothercare: N+1 Singer ups target price from 400p to 450p retaining a buy recommendation.Oxford BioMedica: N+1 Singer lowers target price from 6.60p to 4p keeping its buy recommendation.Pennon Group: Deutsche Bank takes target price from 650p to 680p and maintains its hold recommendation.Phoenix IT Group: Investec ups target price from 150p to 168p and upgrades from hold to buy. Panmure Gordon increases target price from 149p to 167p keeping a hold recommendation.Polymetal International: JP Morgan reduces target price from 1080p to 780p, but upgrades to overweight.Polyus Gold International: JP Morgan lowers target price from 250p to 240p keeping its overweight rating.Sagentia Group: Westhouse Securities downgrades from add to neutral with a target price of 125p.Shaftesbury: UBS moves target price from 58p to 620p and maintains a neutral rating.Shire: Deutsche Bank raises target price from 2170p to 2390p retaining its buy recommendation.United Utilities: Deutsche Bank increases target price from 770p to 850p leaving its buy recommendation unchanged.William Hill: Panmure Gordon takes target price from 475p to 518p and reiterates a buy recommendation.